IBD Drive Time: Russell Cohen, MD, on New Therapies for IBD
Gastroenterology Learning Network
00:00
Comparing Efficacy and Transitioning of Subcutaneous Therapy for IBD
The speakers discuss the subcutaneous formulation of a therapy for IBD and its efficacy compared to the infusion every eight weeks. They also address concerns regarding transitioning patients from different dosing schedules and the importance of monitoring drug levels.
Transcript
Play full episode
